Overview
Currently, the American Association for the Study of Liver Diseases (AASLD) guidelines recommend screening for high-risk hepatitis B antigen carriers rather than all patients with HBV infection for hepatitis delta, although studies suggest HDV screening is rarely implemented.
The goal of this continuing education home study is to increase awareness of hepatitis delta, common signs and symptoms for clinicians to identify, and common risk factors. It is also to inform clinicians on the appropriate screening and treatment recommendations for this population, and the associated adverse effects associated with treatment.
CLAIMING CE CREDIT
This educational activity is provided free of charge.
If you wish to claim CE credit for participation there is a $7.00 accreditation service fee which is paid when you register for the course.
Target Audience
Pharmacists in all practice settings.
Learning Objectives
- List or identify patient-specific risk factors for contracting hepatitis delta
- Breakdown screening recommendations and requirements for diagnosis for patients at risk of hepatitis delta
- Develop patient-centered goals of therapy in those diagnosed with hepatitis delta
- Choose an optimal treatment regimen for viral suppression in patients with hepatitis delta, including dose, frequency, and duration, and determine appropriate post-treatment monitoring
Evaluation
All participants will have the opportunity to review the educational sessions and speakers and to identify future educational needs.
Statement of Disclosure
In accordance with the Accreditation Council for Pharmacy Education (ACPE) Standards for Continuing Pharmacy Education, The University of Rhode Island College of Pharmacy requires that program faculty disclose any relationship (e.g., shareholder, recipient of research grant, consultant or member of an advisory committee) that the faculty may have with commercial companies whose products or services may be mentioned in their presentations. No one involved in the planning of this program has any relevant financial relationships to disclose.
Content Creator
Katherine Houlihan, PharmD, CDOE
Katherine Houlihan is a PGY-2 Ambulatory Care based resident working with Brown University Health. Her prior experience includes home health care and community based pharmacy. Her current areas of interest include public health, harm reduction and primary care.
CE Credit
The accreditation service fee for this program is $7.00
Steps to complete the program and claim credit:
- Complete the course linked below.
- Login or create an account in LUX LMS, URI’s learning management and CE reporting system, using your email address and professional license number. Complete all required account set up fields to ensure accurate CE reporting.
- Select “Available On-Line Activities” or “Home Study Programs” to find the educational activity.
- Select Take Post-Test and proceed to secure online payment (Visa, MC, AMEX, Discover and Electronic Checks are accepted).
Requirements for Credit
Completion of the online educational activity and a program evaluation are required to earn credit. No partial credit is available for this program. Evaluations must be completed at www.uripharmacycpd.org within 60 days.
Pharmacy Accreditation Statement
The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This application-based program will provide 1.0 Contact Hour (0.1 CEU) for pharmacists. UAN: 0060-0000-25-029-H01-P
Release Date: June 18, 2025 Expiration Date: June 18, 2026